KB001-A, a novel anti-inflammatory, found to be safe and well-tolerated in cystic fibrosis patients infected with Pseudomonas aeruginosa

出版年份 2018 全文链接

标题

作者

关键词

出版物

Volume 17, Issue 4, Pages 484-491

出版商

Elsevier BV

发表日期

2017-12-29

DOI

10.1016/j.jcf.2017.12.006

Explore over 38,000 international journals covering a vast array of academic fields.

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now